A series of novel 2-pyridylbenzimidazole derivatives was rationally designed and synthesized based on our previous studies on benzimidazole 14, a CB1 agonist used as a template for optimization. In the present series, 21 compounds displayed high affinities with K-i values in the nanomolar range. JM-39 (compound 39) was the most active of the series (K-iCB1 = 0.53 nM), while compounds 31 and 44 exhibited similar affinities to WIN 55212-2. CoMFA analysis was performed based on the biological data obtained and resulted in a statistically significant CoMFA model with high predictive value (q(2) = 0.710, r(2) = 0.998, r(pred)(2) = 0.823).
%0 Journal Article
%1 RN128
%A Mella-Raipan, J.A.
%A Lagos, C.F.
%A Recabarren-Gajardo, G.
%A Espinosa-Bustos, C.
%A Romero-Parra, J.
%A Pessoa-Mahana, H.
%A Iturriaga-Vasquez, P.
%A Pessoa-Mahana, C.D.
%D 2013
%J Molecules
%K 3d-qsar, agonists, analogs, analysis, binding, cannabinoid, cb1 comfa derivatives, docking, dqcauchile endocannabinoid human-immunodeficiency-virus-(i) inhibitors, molecular-field pharmacology, protease receptor, series, system,
%N 4
%P 3972-4001
%R 10.3390/molecules18043972
%T Design, Synthesis, Binding and Docking-Based 3d-Qsar Studies of 2-Pyridylbenzimidazoles-a New Family of High Affinity Cb1 Cannabinoid Ligands
%U /brokenurl#<Go to ISI>://WOS:000318020100024
%V 18
%X A series of novel 2-pyridylbenzimidazole derivatives was rationally designed and synthesized based on our previous studies on benzimidazole 14, a CB1 agonist used as a template for optimization. In the present series, 21 compounds displayed high affinities with K-i values in the nanomolar range. JM-39 (compound 39) was the most active of the series (K-iCB1 = 0.53 nM), while compounds 31 and 44 exhibited similar affinities to WIN 55212-2. CoMFA analysis was performed based on the biological data obtained and resulted in a statistically significant CoMFA model with high predictive value (q(2) = 0.710, r(2) = 0.998, r(pred)(2) = 0.823).
@article{RN128,
abstract = {A series of novel 2-pyridylbenzimidazole derivatives was rationally designed and synthesized based on our previous studies on benzimidazole 14, a CB1 agonist used as a template for optimization. In the present series, 21 compounds displayed high affinities with K-i values in the nanomolar range. JM-39 (compound 39) was the most active of the series (K-iCB1 = 0.53 nM), while compounds 31 and 44 exhibited similar affinities to WIN 55212-2. CoMFA analysis was performed based on the biological data obtained and resulted in a statistically significant CoMFA model with high predictive value (q(2) = 0.710, r(2) = 0.998, r(pred)(2) = 0.823).},
added-at = {2019-12-04T03:57:35.000+0100},
author = {Mella-Raipan, J.A. and Lagos, C.F. and Recabarren-Gajardo, G. and Espinosa-Bustos, C. and Romero-Parra, J. and Pessoa-Mahana, H. and Iturriaga-Vasquez, P. and Pessoa-Mahana, C.D.},
biburl = {https://www.bibsonomy.org/bibtex/2f6cc4c9382a4be2558f60f44ea3f0e07/dqcauchile},
doi = {10.3390/molecules18043972},
interhash = {74e8d9a73281b64dc964ba68df330809},
intrahash = {f6cc4c9382a4be2558f60f44ea3f0e07},
issn = {1420-3049},
journal = {Molecules},
keywords = {3d-qsar, agonists, analogs, analysis, binding, cannabinoid, cb1 comfa derivatives, docking, dqcauchile endocannabinoid human-immunodeficiency-virus-(i) inhibitors, molecular-field pharmacology, protease receptor, series, system,},
number = 4,
pages = {3972-4001},
timestamp = {2019-12-04T03:58:17.000+0100},
title = {Design, Synthesis, Binding and Docking-Based 3d-Qsar Studies of 2-Pyridylbenzimidazoles-a New Family of High Affinity Cb1 Cannabinoid Ligands},
type = {Journal Article},
url = {/brokenurl#<Go to ISI>://WOS:000318020100024},
volume = 18,
year = 2013
}